MMP-1 and MMP-2 in the Cervix Uteri in Different Steps of Malignant Transformation—An Immunohistochemical Study
- 28 February 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 84 (2) , 222-227
- https://doi.org/10.1006/gyno.2001.6413
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Matrix-metalloproteinases 1, 2 and 3 and their tissue inhibitors 1 and 2 in benign and malignant breast lesions: an in situ hybridization studyVirchows Archiv, 1999
- MMP-2 and TIMP-2 Expression Correlates with Poor Prognosis in Cervical Carcinoma—A Clinicopathologic Study Using Immunohistochemistry and mRNA in Situ HybridizationGynecologic Oncology, 1999
- Control of matrix metalloproteinase activity in cancerThe Journal of Pathology, 1997
- Immunohistochemical localization of matrix metallloproteinase 2 and its specific inhibitor timp‐2 in neoplastic tissues with monclonal antibodiesInternational Journal of Cancer, 1994
- Molecular aspects of tumor cell invasion and metastasisCancer, 1993
- The Matrix Metalloproteinases and Their InhibitorsAmerican Journal of Respiratory Cell and Molecular Biology, 1992
- The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activityBiochemistry, 1991
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- Metalloproteinases and their inhibitors in matrix remodelingTrends in Genetics, 1990
- Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.Proceedings of the National Academy of Sciences, 1989